Trial Profile
Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Oct 2016
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Dapagliflozin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 23 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Aug 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 16 Jun 2009 Additional location 'USA' identified as reported by ClinicalTrials.gov.